Diversified Healthcare Trust DHC
Institutional shares held
180 Million
507K
calls
736K
puts
Total value of holdings
$492M
$1.38M
calls
$2.01M
puts
Market Cap
$653M
239,123,008
Shares Out.
Institutional ownership
75.32%
# of Institutions
194
We take great care to ensure that the data presented and summarized in this overview for DIVERSIFIED HEALTHCARE TRUST is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding DHC
View all-
Flat Footed LLC Wilson, WY23.5MShares$64.1 Million12.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.8MShares$54 Million0.0% of portfolio
-
Black Rock Inc. New York, NY18.4MShares$50.1 Million0.0% of portfolio
-
Silver Point Capital L.P. Greenwich, CT15.5MShares$42.3 Million2.33% of portfolio
-
H/2 Credit Manager LP Stamford, CT14.9MShares$40.7 Million9.41% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY13.5MShares$36.8 Million0.03% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA10.9MShares$29.8 Million0.01% of portfolio
-
Nomura Holdings Inc Tokyo, M09.59MShares$26.2 Million0.06% of portfolio
-
State Street Corp Boston, MA6.63MShares$18.1 Million0.0% of portfolio
-
Lonestar Capital Management LLC Menlo Park, CA6.49MShares$17.7 Million14.95% of portfolio
Latest Institutional Activity in DHC
Top Purchases
Top Sells
About DHC
DHC is a real estate investment trust, or REIT, that owns medical office and life science properties, senior living communities and wellness centers throughout the United States. DHC is managed by the operating subsidiary of The RMR Group Inc., an alternative asset management company that is headquartered in Newton, MA.
Insider Transactions at DHC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 31
2024
|
Phyllis M. Hollis Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,037
+39.34%
|
-
|
|
May 31
2024
|
Jeffrey P. Somers Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,037
+21.46%
|
-
|
|
May 31
2024
|
John L. Harrington Director |
BUY
Bona fide gift
|
Indirect |
37,037
+27.62%
|
-
|
|
May 31
2024
|
John L. Harrington Director |
SELL
Bona fide gift
|
Direct |
37,037
-100.0%
|
-
|
|
May 31
2024
|
John L. Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,037
+50.0%
|
-
|
|
May 31
2024
|
Christopher J. Bilotto President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
37,037
+30.13%
|
-
|
|
May 31
2024
|
Adam D. Portnoy Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,037
+12.84%
|
-
|
|
May 31
2024
|
Dawn K. Neher Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,037
+50.0%
|
-
|
|
May 31
2024
|
Lisa Harris Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,037
+22.49%
|
-
|
|
Sep 26
2023
|
Phyllis M. Hollis Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Sep 18
2023
|
Jennifer F. Francis President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,839
-5.82%
|
$31,678
$2.33 P/Share
|
|
Sep 18
2023
|
Richard W. Siedel Jr. CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,086
-7.39%
|
$14,172
$2.33 P/Share
|
|
Sep 13
2023
|
Jennifer F. Francis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+18.07%
|
-
|
|
Jun 14
2023
|
Adam D. Portnoy Director |
BUY
Open market or private purchase
|
Indirect |
2,000,000
+7.92%
|
$6,000,000
$3.07 P/Share
|
|
Jun 13
2023
|
Adam D. Portnoy Director |
BUY
Open market or private purchase
|
Indirect |
1,992,259
+8.57%
|
$5,976,777
$3.03 P/Share
|
|
Jun 12
2023
|
Adam D. Portnoy Director |
BUY
Open market or private purchase
|
Indirect |
2,011,256
+9.46%
|
$4,022,512
$2.87 P/Share
|
|
Jun 09
2023
|
Adam D. Portnoy Director |
BUY
Open market or private purchase
|
Indirect |
1,905,200
+9.95%
|
$3,810,400
$2.59 P/Share
|
|
Jun 08
2023
|
Adam D. Portnoy Director |
BUY
Open market or private purchase
|
Indirect |
1,690,000
+9.92%
|
$3,380,000
$2.46 P/Share
|
|
Jun 07
2023
|
Adam D. Portnoy Director |
BUY
Open market or private purchase
|
Indirect |
2,400,000
+14.95%
|
$4,800,000
$2.34 P/Share
|
|
Jun 06
2023
|
Adam D. Portnoy Director |
BUY
Open market or private purchase
|
Indirect |
1,603,082
+12.47%
|
$1,603,082
$1.87 P/Share
|
Last 12 Months Summary
Buy / Acquisition
12.4M
Shares
From
10
Insiders
| Grant, award, or other acquisition | 339K shares |
|---|---|
| Open market or private purchase | 12M shares |
| Bona fide gift | 37K shares |
Sell / Disposition
60K
Shares
From
3
Insiders
| Payment of exercise price or tax liability | 22.9K shares |
|---|---|
| Bona fide gift | 37K shares |